Titan Pharmaceuticals
TTNP
$6.88
Share price
-2.55%
Change (1 day)
805.26%
Change (1 year)
Categories
Titan Pharmaceuticals (TTNP) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $1.44 M
According to Titan Pharmaceuticals 's latest financial reports the company's total liabilities are $1.44 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Titan Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $2.69 M | -5.64% |
| 2021-12-31 | $2.85 M | -37.3% |
| 2020-12-31 | $4.55 M | -43.69% |
| 2019-12-31 | $8.08 M | 11.36% |
| 2018-12-31 | $7.26 M | -9.74% |
| 2017-12-31 | $8.04 M | 46.97% |
| 2016-12-31 | $5.47 M | -13.04% |
| 2015-12-31 | $6.29 M | -48.55% |
| 2014-12-31 | $12.24 M | -3.34% |
| 2013-12-31 | $12.66 M | -73.59% |
| 2012-12-31 | $47.95 M | 58.29% |
| 2011-12-31 | $30.29 M | 180.39% |
| 2010-12-31 | $10.8 M | 174.73% |
| 2009-12-31 | $3.93 M | |
| 2007-12-31 | $4.25 M | 25.4% |
| 2006-12-31 | $3.39 M | 8.23% |
| 2005-12-31 | $3.13 M | -14.6% |
| 2004-12-31 | $3.67 M | 9.91% |
| 2003-12-31 | $3.34 M | -15.31% |
| 2002-12-31 | $3.94 M | -31.56% |
| 2001-12-31 | $5.76 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 6,840,897.23% | 🇺🇸 USA |
 Novartis NVS | $54.57 B | 3,779,539.89% | 🇨🇭 Switzerland |
 Vanda Pharmaceuticals VNDA | $0.10 B | 7,069.67% | 🇺🇸 USA |
 Repligen
RGEN | $0.85 B | 58,986.43% | 🇺🇸 USA |
 MediciNova MNOV | $3.89 M | 169.50% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $36.45 M | 2,424.65% | 🇺🇸 USA |